Have a personal or library account? Click to login
Prescribers’ approval rate of pharmacist-initiated interventions to optimise patients’ clinical status of hypertension in the ambulatory care setting Cover

Prescribers’ approval rate of pharmacist-initiated interventions to optimise patients’ clinical status of hypertension in the ambulatory care setting

Open Access
|Dec 2023

References

  1. World Health Organization (WHO), Hypertension, World Health Organization, March 2023; https://www.who.int/news-room/fact-sheets/detail/hypertension; last access date September 4, 2023.
  2. Croatian Institute of Public Health, Croatian Health Statistics Yearbook 2021; Croatian Institute of Public Health: January 2023; https://www.hzjz.hr/wp-content/uploads/2023/05/HZSLj_-_2021_v._05.2023..pdf; last access date September 5, 2023.
  3. D. M. Levine, J. A. Linder and B. E. Landon, The quality of outpatient care delivered to adults in the United States, 2002 to 2013, JAMA Intern. Med. 176(12) (2016) 1778–1790; https://doi.org/10.1001/jamainternmed.2016.6217
  4. J. A. Johnson and J. L. Bootman, Drug-related morbidity and mortality and the economic impact of pharmaceutical care, Am. J. Heal. Pharm. 54(5) (1997) 554–558; https://doi.org/10.1093/ajhp/54.5.554
  5. F. R. Ernst and A. J. Grizzle, Drug-related morbidity and mortality: Updating the cost-of-illness model, J. Am. Pharm. Assoc. 41(2) (2001) 192–199; https://doi.org/10.1016/S1086-5802(16)31229-3
  6. H. Watanabe, T. McInnis and J. D. Hirsch, Cost of prescription drug–related morbidity and mortality, Ann. Pharmacother. 52(9) (2018) 829–837; https://doi.org/10.1177/1060028018765159
  7. C. J. Charlesworth, E. Smit, D. S. H. Lee, F. Alramadhan and M. C. Odden, Polypharmacy among adults aged 65 years and older in the United States: 1988–2010, J. Gerontol. – Ser. A. Biol. Sci. Med. Sci. 70(8) (2015) 989–995; https://doi.org/10.1093/gerona/glv013
  8. Government of the Republic of Croatia, Ministry of Health of the Republic of Croatia, National Health Care Strategy 2021–2027; December 2021, https://zdravlje.gov.hr/UserDocsImages/2022Objave/Nacionalniplan razvoja zdravstva 2021.–2027.pdf; last accessed September 1, 2023.
  9. T. McInnis, L. Strand and C. E. Webb, Integrating Comprehensive Medication Management to Optimize Patient Outcomes, Resource Guide, 2nd ed. Washington, DC: Patient-Centered Primary Care Collaborative, June 2012; https://www.pcpcc.org/sites/default/files/media/medmanagement.pdf; last access date September 10, 2023.
  10. S. E. McBane, A. L. Dopp, A. Abe, S. Benavides, E. A. Chester, D. L. Dixon, M. Dunn, M. D. Johnson, S. J. Nigro, T. Rothrock-Christian, A. H. Schwartz, K. Thrasher and S. Walker, Collaborative drug therapy management and comprehensive medication management – 2015, Pharmacotherapy 35(4) (2015) e39–e50; https://doi.org/10.1002/phar.1563
  11. American College of Clinical Pharmacy, Comprehensive Medication Management in Team-Based Care, 2017; https://www.accp.com/docs/positions/misc/CMM%20Brief.pdf; last access date September 4, 2023.
  12. M. S. McFarland, M. Buck, L. Armistead, J. Jacobi and M. A. Kliethermes, The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of The Evidence on Quality, Access and Costs, October 2020 GTMRx Institute, 2020; https://gtmr.org/wp-content/; last access date September 4, 2023.
  13. R. J. Cipolle, L. M. Strand and P. C. Morley, Pharmaceutical Care as the Professional Practice for Patient-Centered Medication Management Services, in Pharmaceutical Care Practice the Patient-Centered Approach to Medication Management Services, 3rd ed, The McGraw-Hill Companies, New York 2012, pp. 37–72.
  14. M. S. McFarland, M. Buck, L. Armistead, J. Jacobi and M. A. Kliethermes, The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2022, GTMRx Institute 2022; https://gtmr.org/resources/the-outcomes-of-implementing-and-integrating-cmm-in-team-based-care-a-review-of-the-evidence-on-quality-access-and-costs/; last access date August 30, 2023.
  15. H. L. Maracle, D. Pharm, D. R. de Oliveira, D. Ph, A. Brummel and D. Pharm, Primary care providers’ experiences with pharmaceutical care-based medication therapy management services, Innov. Pharm. 3(1) (2012) 1–12; https://doi.org/10.24926/iip.v3i1.255
  16. K. A. Funk, D. L. Pestka, M. T. Roth McClurg, J. K. Carroll and T. D. Sorensen, Primary care providers believe that comprehensive medication management improves their work-life, J. Am. Board Fam. Med. 32(4) (2019) 462–473; https://doi.org/10.3122/jabfm.2019.04.180376
  17. M. S. McFarland, K. Lamb, J. Hughes, A. Thomas, J. Gatwood and J. Hathaway, Perceptions of integration of the clinical pharmacist into the patient care medical home model, J. Healthc. Qual. 40(5) (2018) 265–273; https://doi.org/10.1097/JHQ.0000000000000114
  18. P. N. Perera, M. C. Guy, A. M. Sweaney and K. P. Boesen, Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP), J. Manag. Care Pharm. 17(5) (2011) 345–354; https://doi.org/10.18553/jmcp.2011.17.5.345
  19. K. B. Detoni, I. V. Oliveira, M. M. G. Nascimento, T. R. Caux, M. R. Alves and D. R. de Oliveira, Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease, Int. J. Clin. Pharm. 39(1) (2016) 95–103; https://doi.org/10.1007/s11096-016-0402-6
  20. R. J. Cipolle, L. M. Strand and P. C. Morley, Drug Therapy Problems, in Pharmaceutical Care Practice the Patient-Centered Approach to Medication Management Services, 3rd ed, The McGraw-Hill Companies, New York 2012, pp. 141–182.
  21. D. R. de Oliveira, A. R. Brummel and D. B. Miller, Medication therapy management: 10 years of experience in a large integrated health care system, J. Manag. Care Pharm. 16(3) (2010) 185–195; https://doi.org/10.18553/jmcp.2010.16.3.185
  22. B. J. Isetts, S. W. Schondelmeyer, M. B. Artz, L. Lenarz, A. H. Heaton, W. B. Wadd, L. M. Brown and R. J. Cipolle, Clinical and economic outcomes of medication therapy management services: The Minnesota experience, J. Am. Pharm. Assoc. 48(2) (2008) 203–214; https://doi.org/10.1331/JAPhA.2008.07108
  23. A. Brajković, I. Mucalo, T. Vidović, M. Martins Gonzaga do Nascimento, A. Balenović, I. Protrka and D. R. de Oliveira, Implementation of medication management services at the primary health-care level – a pilot study, Acta Pharm. 69(4) (2019) 585–606; https://doi.org/10.2478/acph-2019-0055
  24. A. Brajković, L. Bosnar, M. M. G. Do Nascimento, I. Prkačin, A. Balenović, D. R. de Oliveira and I. Mucalo, Healthcare utilisation and clinical outcomes in older cardiovascular patients receiving comprehensive medication management services: A nonrandomised clinical study, Int. J. Environ. Res. Public Health 19(5) (2022) Article ID 2781 (11 pages); https://doi.org/10.3390/ijerph19052781
  25. B. L. Carter, G. Ardery, J. D. Dawson, P. A. James, G. R. Bergus, W. R. Doucette, E. A. Chrischilles, C. L. Franciscus and Y. Xu, Physician and pharmacist collaboration to improve blood pressure control, Arch. Intern. Med. 169(21) (2009) 1996–2002; https://doi.org/10.1001/archinternmed.2009
  26. B. A. Bunting, B. H. Smith and S. E. Sutherland, The Asheville Project: Clinical and economic outcomes of a community-based long-term medication therapy management program for hyper-tension and dyslipidemia, J. Am. Pharm. Assoc. 48(1) (2008) 23–31; https://doi.org/10.1331/JAPhA.2008.07140
  27. C. de M. Neves, M. M. G. do Nascimento, D. Á. M. Silva and D. R. de Oliveira, Clinical results of comprehensive medication management services in primary care in belo horizonte, Pharmacy 7(2) (2019) Article ID 58 (10 pages); https://doi.org/10.3390/pharmacy7020058
  28. C. de P. Rezende, M. M. G. do Nascimento, S. G. Ferreira, B. D. Santos, C. de M. Neves, G. C. B. de Oliveira, Y. de A. Nascimento and D. Ramalho-de-Oliveira, Clinical impact of comprehensive medication management services offered to geriatric and hypertensive patients, J. Pharm. Health. Serv. Res, 14(3) (2023) 285–290; https://doi.org/10.1093/jphsr/rmad028
  29. M. D. Rivera, M. Johnson, H. M. Choe, J. M. Durthaler, J. R. Elmi, E. B. Fulmer, N. A. Hawkins, J. K. Jordan, K. E. MacLeod, A. M. Ortiz, S. S. Shantharam, B. O. Yarnoff and C. S. Soloe, Evaluation of a pharmacists’ patient care process approach for hypertension, Am. J. Prev. Med. 62(1) (2022) 100–104; https://doi.org/10.1016/j.amepre.2021.06.012
  30. B. D. Santos, M. M. G. do Nascimento, G. C. B. de Oliveira, Y. de A. Nascimento, J. V. de M. Mambrini, A. S. Cid, T. G. C. Piovesan, L. B. Fernandes, U. C. de M. Martins, C. de M. Neves, D. F. da Silva and D. R. de Oliveira, Clinical impact of a comprehensive medication management service in primary health care, J. Pharm. Pract. 34(2) (2021) 265–271; https://doi.org/10.1177/0897190019866309
  31. A. J. Zillich, H. A. Jaynes, S. D. Bex, A. S. Boldt, C. M. Walston, D. C. Ramsey, J. M. Sutherland and D. M. Bravata, Evaluation of pharmacist care for hypertension in the veterans affairs patient-centered medical home: A retrospective case-control study, Am. J. Med. 128(5) (2015) 539.e1-539. e6 (6 pages); https://doi.org/10.1016/j.amjmed.2014.11.027
  32. A. O. M. Mourão, W. R. Ferreira, M. A. P. Martins, A. M. M. Reis, M. R. G. Carrillo, A. G. Guimarães and L. S. Ev, Pharmaceutical care program for type 2 diabetes patients in Brazil: A randomised controlled trial, Int. J. Clin. Pharm. 35(1) (2013) 79–86; https://doi.org/10.1007/s11096-012-9710-7
  33. L. G. Planas, K. M. Crosby, K. D. Mitchell and K. C. Farmer, Evaluation of a hypertension medication therapy management program in patients with diabetes, J. Am. Pharm. Assoc. (2003) 49(2) (2009) 164–170; https://doi.org/10.1331/JAPhA.2009.08164
  34. B. M. Bluml, J. M. McKenney and M. J. Cziraky, Pharmaceutical care services and results in project ImPACT: hyperlipidemia, J. Am. Pharm. Assoc. 40(2) (2000) 157–165; https://doi.org/10.1016/S1086-5802(16)31059-2
  35. C. W. Cranor and D. B. Christensen, The Asheville Project: Short-term outcomes of a community pharmacy diabetes care program, J. Am. Pharm. Assoc. 43(2) (2003) 149–159; https://doi.org/10.1331/108658003321480704
  36. B. J. Isetts, L. M. Brown, S. W. Schondelmeyer and L. A. Lenarz, Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals, Arch. Intern. Med. 163(15) (2003) 1813–1820; https://doi.org/10.1001/archinte.163.15.1813
  37. L. M. Strand, R. J. Cipolle, P. C. Morley and M. J. Frakes, The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience, Curr. Pharm. Des. 10(31) (2004) 3987–4001; https://doi.org/10.2174/1381612043382576
  38. S. J. Muenster, B. L. Carter, C. A. Weber, M. E. Ernst, J. L. Milchak, J. J. G. Steffensmeier and Y. Xu, Description of pharmacist interventions during physician–pharmacist co-management of hyper-tension, Pharm. World. Sci. 30(1) (2007) 128–135; https://doi.org/10.1007/s11096-007-9155-6
  39. D. G. Haxby, C. W. Weart and B. W. Goodman, Family practice physicians’ perceptions of the usefulness of drug therapy recommendations from clinical pharmacists, Am. J. Hosp. Pharm. 45(4) (1988) 824–827.
  40. B. DeName, H. Divine, A. Nicholas, D. T. Steinke and C. L. Johnson, Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the Diabetes Care program, J. Am. Pharm. Assoc. 48(6) (2008) 731–736; https://doi.org/10.1331/JA-PhA.2008.07070
  41. W. R. Doucette, R. P. McDonough, D. Klepser and R. McCarthy, Comprehensive medication therapy management: Identifying and resolving drug-related issues in a community pharmacy, Clin. Ther. 27(7) (2005) 1104–1111; https://doi.org/10.1016/S0149-2918(05)00146-3
  42. M. McCollum, W. Nuffer, S. L. Ellis and C. J. Turner, Physician acceptance of pharmacotherapy recommendations made by pharmacy students in a rural pharmacy-based diabetes care and education clinic, Am. J. Pharm. Educ. 73(2) (2009) Article ID 24 (4 pages); https://doi.org/10.5688/aj730224
  43. K. F. Šola, I. Mucalo, A. Brajković, I. Jukić, D. Verbanac and S. Vladimir Knežević, Drug therapy problems identified among older adults placed in a nursing home: The Croatian experience, J. Int. Med. Res. 48(6) (2020) Article ID 030006052092879 (15 pages); https://doi.org/10.1177/0300060520928791
  44. B. J. Isetts, Evaluating Effectiveness of the Minnesota Medication Therapy Management Care Program: Final Report, Minnnesota Legislature, December 2007; last access date September 8, 2023.
  45. D. Rao, A. Gilbert, L. M. Strand and R. J. Cipolle, Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia, Pharm. World Sci. 29(6) (2007) 647–654; https://doi.org/10.1007/s11096-007-9123-1
DOI: https://doi.org/10.2478/acph-2023-0047 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 723 - 734
Accepted on: Dec 11, 2023
Published on: Dec 26, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2023 Andrea Brajković, Lucija Ana Bićanić, Helena Orehovački, Ingrid Prkačin, Djenane Ramalho De Oliveira, Iva Mucalo, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.